Unisan Formulations Private Limited

Unisan Formulations Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2003PTC161277 Incorporated 09 July 2003 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2020
₹1.15 Cr
▲ 48% YoY
Net profit · FY 2020
₹75,537
Net margin 0.7%
EBITDA · FY 2020
₹1.68 Lakh
EBITDA margin 1.5%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.8 Cr
Issued & subscribed
Satisfied charges
₹83 Lakh
No open charges
Company age
23 yrs
Est. 2003
Employees · EPFO
5
Provident fund records

About Unisan Formulations Private Limited

Data last updated:

Unisan Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 July 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PTC161277. Its GSTIN is 36AAACW4896M2ZJ (Telangana). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.8 Cr. It was formerly known as Uni-San Lifecare Private Limited and Waksman Selman Pharmaceuticals Private Limited. It is led by directors including Venkateswara Rao Jampana (Managing Director) and Rushikesh Medam.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2020, the company reported a revenue of ₹1.15 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹75,537 (net margin 0.7%) and EBITDA of ₹1.68 Lakh (EBITDA margin 1.5%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.

The company has about 5 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹83 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.

Unisan Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0011343). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website waksmanselmanpharma.com.

Company details

CIN U24239TG2003PTC161277
Registration Number 161277
Incorporation Date 09 July 2003
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0011343

Name history

Unisan Formulations has undergone 3 name changes throughout its history. The company was previously known as Uni-San Lifecare Private Limited, Waksman Selman Pharmaceuticals Private Limited, and Uni-San Healthcare Private Limited. The current legal name is Unisan Formulations Private Limited.

Company NameStatus
Unisan Formulations Private LimitedCurrent
Uni-San Lifecare Private LimitedPrevious
Waksman Selman Pharmaceuticals Private LimitedPrevious
Uni-San Healthcare Private LimitedPrevious

CIN history

Unisan Formulations has one previous CIN (Corporate Identification Number): U24239AP2003PTC041320. The current CIN is U24239TG2003PTC161277, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG2003PTC161277Current
U24239AP2003PTC041320Previous
Key People
Venkateswara Rao Jampana Managing Director Rushikesh Medam Director Madallapalli Saritha Additional Director

Recognitions & Rankings of Unisan Formulations

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-09-0011343

Contact details

Unisan Formulations Private Limited's registered office is in Hyderabad, Telangana. Its website is waksmanselmanpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    waksmanselmanpharma.com
  • Social Media
  • Registered Address
    House No. 5 – 5 – 35/167, Apiic Main Road Prashanth Nagar, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Unisan Formulations Private Limited, buy the company report.

Comprehensive company report
Unisan Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Unisan Formulations Private Limited

FY 2025 filings available

Unisan Formulations Private Limited reported revenue of ₹1.15 Cr (up 48% YoY) for FY 2020.

Revenue · FY 2020
₹1.15 Cr ▲ 48%
Net profit · FY 2020
₹75,537 margin 0.7%
EBITDA · FY 2020
₹1.68 Lakh margin 1.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 48%
3 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▼ 51%
3 years · compounded
▼ 42%
5 years · compounded
▼ 29%

Revenue rose 48% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA fell 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1.15 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.68 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹75,537
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin1.5%
Net Profit Margin0.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Unisan Formulations Private Limited, buy the company report.

Board of directors of Unisan Formulations Private Limited

Unisan Formulations has 3 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rushikesh MedamDirector21 Oct 20224 Years 0 MonthsCurrent
Venkateswara Rao JampanaManaging Director22 Aug 201610 Years 2 MonthsCurrent
Madallapalli SarithaAdditional Director01 Jan 20260 Years 10 MonthsCurrent
View all directors

Auditor

Unisan Formulations Private Limited is audited by GONDI NAGARAJU & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
GONDI NAGARAJU & COFY 2019007219S

Shareholding

The shareholding of Unisan Formulations Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Unisan Formulations Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹83 Lakh
Breakdown by lending institutions
City Union Bank Limited₹0.60 Cr
State Bank of India₹0.23 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Sep 200810125419City Union Bank Limited₹60 LakhSatisfied
25 Jul 200380049535State Bank of India₹6 LakhSatisfied
25 Jul 200390128414State Bank of India₹17 LakhSatisfied

To see the full charge records of Unisan Formulations Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Unisan Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Unisan Formulations Private Limited has a workforce of 5 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.

Employee count
5
Active EPFO establishments
1
Employee growth
-61.54%

GST

Unisan Formulations has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAACW4896M2ZJTelanganaActive21 Jul 2020
37AAACW4896M1ZIAndhra PradeshActive27 Jul 2017

To see the full GST registrations and return filing status of Unisan Formulations Private Limited, buy the company report.

Recent activity

Unisan Formulations Private Limited has 15 board changes on record since 2013: 3 appointments and 12 cessations. The latest: Madallapalli Saritha was appointed as Additional Director on 01 Jan 2026.

Appointed
Madallapalli Saritha was appointed as Additional Director.
AGM
Unisan Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Unisan Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Madallapalli Saritha ceased to be Managing Director.
Appointed
Rushikesh Medam was appointed as Director.
Ceased
Venkateswara Rao Jampana ceased to be Director.
Charges
A charge registered on 29 Sep 2008 via Charge ID 10125419 with City Union Bank Limited was fully satisfied on 05 Jan 2022.
Ceased
Madhavi Reddy Pothireddy ceased to be Additional Director.
Appointed
Venkateswara Rao Jampana was appointed as Managing Director.
Ceased
Anand Katta ceased to be Managing Director.
Ceased
Pavan Kumar Nallamala ceased to be Director.
Ceased
Ushadevi Katta ceased to be Director.

14 earlier events are in the company report.

Frequently asked questions

Unisan Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 July 2003 (23+ years old) and is registered under CIN U24239TG2003PTC161277.

Unisan Formulations has 3 current directors:

The latest financial statements of Unisan Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Unisan Formulations is 36AAACW4896M2ZJ, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 37AAACW4896M1ZI (Andhra Pradesh).

The CIN (Corporate Identification Number) of Unisan Formulations is U24239TG2003PTC161277. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Unisan Formulations has 1 court case on record: 1 filed by the company.

Unisan Formulations was incorporated on 09 July 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.

Madallapalli Saritha was appointed as Additional Director on 01 Jan 2026. Madallapalli Saritha ceased to be Managing Director on 21 Oct 2022. Rushikesh Medam was appointed as Director on 21 Oct 2022. Unisan Formulations has 15 board changes on record in total.

Yes, Unisan Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0011343).

Unisan Formulations can be reached through the website waksmanselmanpharma.com. Its registered office is in Hyderabad, Telangana, India.